Printer Friendly

Research and Markets: Cardiovascular Inflammation - Pipeline Review, H2 2012.

DUBLIN -- Research and Markets ( has announced the addition of Global Markets Direct's new report "Cardiovascular Inflammation - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Cardiovascular Inflammation - Pipeline Review, H2 2012', provides an overview of the Cardiovascular Inflammation therapeutic pipeline. This report provides information on the therapeutic development for Cardiovascular Inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Inflammation. 'Cardiovascular Inflammation - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

- A snapshot of the global therapeutic scenario for Cardiovascular Inflammation.

- A review of the Cardiovascular Inflammation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Cardiovascular Inflammation pipeline on the basis of route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables of Figures 4

Introduction 5


Cardiovascular Inflammation Overview 6

Therapeutics Development 7

An Overview of Pipeline Products for Cardiovascular Inflammation 7

Cardiovascular Inflammation Therapeutics under Development by Companies 9

Cardiovascular Inflammation Therapeutics under Investigation by Universities/Institutes 10

Mid Clinical Stage Products 11

Comparative Analysis 11

Early Clinical Stage Products 12

Comparative Analysis 12

Discovery and Pre-Clinical Stage Products 13

Comparative Analysis 13

Cardiovascular Inflammation Therapeutics - Products under Development by Companies 14

Cardiovascular Inflammation Therapeutics - Products under Investigation by Universities/Institutes 15

Companies Involved in Cardiovascular Inflammation Therapeutics Development 16

Cardiovascular Inflammation - Therapeutics Assessment 22

Assessment by Monotherapy Products 22

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Drug Profiles 27

Product Description 35

Mechanism of Action 35

R&D Progress 35

Venilon - Drug Profile 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Vascostem - Drug Profile 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Appendix 44

For more information visit

Source: Global Markets Direct
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 17, 2012
Previous Article:Research and Markets: The Top 10 Energy & Communications Infrastructure Projects in Middle East and Africa : Project Guide.
Next Article:Research and Markets: Threats and Opportunities in the Mining Industry - 2012-2013 : Survey Brief.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters